Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types

Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types

Respiratory Syncytial Virus (RSV) causes serious respiratory tract illness and substantial morbidity and some mortality in populations at the extremes of age, i.e., infants, young children, and the elderly. To date, RSV vaccine development has been unsuccessful, a feature linked to the lack of bioma...

Full description

Bibliographic Details
Main Authors: Lydia J. Atherton, Patricia A. Jorquera, Abhijeet A. Bakre, Ralph A. Tripp
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Immunology
Subjects:
RSV
miR
vaccines
immune
disease
microRNA
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.02323/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.02323/full

Similar Items